vTv Therapeutics (STU:5VT0) Float Percentage Of Total Shares Outstanding: 60.51% (As of Jul. 24, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:5VT0 vTv Therapeutics Inc STU:5VT0
33 GF Score
Price €27.20
View Full Analysis

What is vTv Therapeutics Float Percentage Of Total Shares Outstanding?

vTv Therapeutics STU:5VT0 33 Float Percentage Of Total Shares Outstanding is 60.51% as of Jul. 24, 2026. GuruFocus rates STU:5VT0 with a GF Score™ of 33/100.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, vTv Therapeutics's float shares is 2.38 Mil. vTv Therapeutics's total shares outstanding is 3.94 Mil. vTv Therapeutics's float percentage of total shares outstanding is 60.51%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, vTv Therapeutics's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, vTv Therapeutics's Institutional Ownership is 11.80%.

STU:5VT0
33GF Score
vTv Therapeutics Inc STU:5VT0
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

vTv Therapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

vTv Therapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=2.38/3.94
=60.51%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 60.51% mean?
vTv Therapeutics (STU:5VT0) has a Float Percentage Of Total Shares Outstanding of 60.51% as of Jul. 24, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on vTv Therapeutics and its competitors.
Is vTv Therapeutics' Float Percentage Of Total Shares Outstanding too high?
vTv Therapeutics' current Float Percentage Of Total Shares Outstanding is 60.51%. Overall, vTv Therapeutics has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does vTv Therapeutics' Float Percentage Of Total Shares Outstanding compare to SMNR and CNTB?
vTv Therapeutics' Float Percentage Of Total Shares Outstanding of 60.51% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on vTv Therapeutics and its competitors. vTv Therapeutics's current Float Percentage Of Total Shares Outstanding is 60.51%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is vTv Therapeutics stock overvalued right now?
vTv Therapeutics (STU:5VT0) has a current Float Percentage Of Total Shares Outstanding of 60.51%. The current Float Percentage Of Total Shares Outstanding is 60.51%. vTv Therapeutics' overall GF Score™ is 33/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For vTv Therapeutics (STU:5VT0), the current Float Percentage Of Total Shares Outstanding is 60.51% as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

vTv Therapeutics Business Description

Other Exchanges VTVT:USA
Address 3980 Premier Drive, Suite 110, High Point, NC, USA, 27265
vTv Therapeutics Inc is a late-stage biopharmaceutical company focused on developing oral, small-molecule drug candidates intended to help treat people living with diabetes and other chronic diseases. Its clinical pipeline is led by cadisegliatin (TTP399), a novel, small-molecule, liver-selective glucokinase activator (GKA) currently being evaluated as a potential oral adjunctive therapy to insulin for the treatment of type 1 diabetes (T1D). In addition, the company is also engaged in the research and development of other candidates in its pipeline through collaborations with academic partners and license agreements, which include TTP273, HPP737, TTP-RA, Mavodelpar (HPP593), HPP971, and HPP3033, being studied and developed to counter various chronic diseases.
33GF Score

Get the complete analysis for STU:5VT0

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€27.20
Price